Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Hao Zhang
Northwestern University at Chicago, Department: Ophthalmology
Should you be removed from our database? Contact us at [email protected]. Read more below.
Opticent Health
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
The research is related to the focus of an entity in which Professor Zhang has significant financial interests, Opticent Health. Opticent Health is working to produce a next generation Optical Coherence Tomography (OCT) device with improved resolution over existing devices and the ability to determine functional information about imaged vasculature. Opticent Health is also working on high resolution fabrication and the design and manufacture of optical medical devices tailored for individual patients, providing better performance and a host of novel features over existing devices.
This research will test the hypothesis that imaging of the retinal metabolic rate of oxygen, using an innovative OCT approach, can provide a much-needed, non-invasive biomarker of diabetic microvascular disease.
The close intersection of this research and Professor Zhang’s Opticent Health’s interests, particularly relative to OCT, results in the perception of a conflict of interest that should be managed.
Functional Retinal Imaging to Monitor Pharmaco-Therapies in Diabetic Retinopathy
This proposal aims to validate a novel non-invasive imaging device capable of monitoring the health of the eye and response to therapy of diabetic complications in the eye. Success of this proposal will lead to non-invasive imaging approaches that can detect the health of the retina as well as identify patients at high risk of diabetic complications in the eye and elsewhere.
Filed on November 18, 2015.
Tell us what you know about Hao Zhang's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Hao Zhang filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Hao Zhang | Northwestern University | Conflict of Interest | Opticent Health | Value cannot be readily determined |
| Hao Zhang | Florida International University | Conflict of Interest | Opticent Health | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.